PATENT CLAIM ANALYSIS

Application Number: 15938837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "399000"]

Abstract:
Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.

Claim (Index 10):
The formulation of  claim 1 , comprising five or more of the following amino acids as modified release amino acids in the recited weight parts: Amino Acid Weight Parts L-Alanine \u20022.0-12.0 L-Arginine \u20023.0-10.5 L-Aspartic Acid \u20025.0-10.5 L-Cystine 1.5-4.0 L-Glutamic Acid + \u20027.0-25.0 Glutamine Glycine \u20023.5-15.0 L-Histidine 2.0-6.5 L-Isoleucine 2.0-8.5 L-Leucine \u20028.0-15.0 L-Lysine \u20024.5-10.5 L-Methionine 1.0-3.0 L-Phenylalanine 4.0-7.5 L-Proline \u20023.5-15.0 L-Serine 2.0-8.5 L-Threonine 4.0-7.5 L-Tryptophan 1.0-4.0 L-Tyrosine \u20022.5-14.0 L-Valine \u20022.5-10.0 L-Carnitine 0.0-0.2 Taurine 0.05-1.0

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15655924', '12714181', '12433510', '10364793', '10943356']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6885099904124348
- 35 USC 102 Novelty (BERT): 0.5102843347594501
- Combined Prediction Score: 0.6706874248471363
- Mean Citation Score: 224.945836
- Max Citation Score: 259.45892000000003
- Similarity Product: 185.07761234808925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test